Showing results (11-20 of 84) with videos related to

Sort By:
Pageof 9
La Revue Du Praticien|April 1, 1990
[Epidemiologic and prognostic factors of cancer of the breast]J Rouëssé, J Berlie, K Hacene, et al.
Anticancer Research|August 6, 2000
Nonlinear discriminant analysis and prognostic factor classification in node-negative primary breast cancer using probabilistic neural networksJ M Le Goff, L Lavayssière, J Rouëssé, et al.
Cancer Detection and Prevention|January 1, 1985
Glycolytic enzymes in human breast carcinoma cytosols: the influence of commonly used reference parametersJ Oglobine, F Spyratos, R Lidereau, et al.
Cytometry|January 1, 1990
Flow cytometric analysis of DNA content and keratins by using CK7, CK8, CK18, CK19, and KL1 monoclonal antibodies in benign and malignant human breast tumorsM Ferrero, F Spyratos, V Le Doussal, et al.
Breast Cancer Research and Treatment|January 1, 1996
Improvement of quality control for steroid receptor measurements: analysis of distributions in more than 40000 primary breast cancers. French Study Group on Tissue and Molecular BiopathologyS Romain, F Spyratos, J Goussard, et al.
British Journal of Cancer|February 1, 1994
pS2 and response to adjuvant hormone therapy in primary breast cancerF Spyratos, C Andrieu, K Hacène, et al.
Archives D'Anatomie Et De Cytologie Pathologiques|January 1, 1994
[Intra-tissue biological markers in cancers of the breast: current assessment]S Romain, F Spyratos, J Goussard, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1989
Prognostic value of estrogen and progesterone receptors in primary infiltrating ductal breast cancer. A sequential multivariate analysis of 1262 patientsF Spyratos, K Hacene, M Tubiana-Hulin, et al.
The International Journal of Biological Markers|October 11, 2003
Limited prognostic value of c-erbB-2 compared to uPA and PAI-1 in primary breast carcinomaC Bouchet, M Ferrero-Poüs, K Hacène, et al.
Analytical and Quantitative Cytology and Histology|December 1, 1987
Flow cytometric study of DNA distribution in cytopunctures of benign and malignant breast lesionsF Spyratos, M Briffod, A Gentile, et al.
Pageof 9